3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma, Synovial
1
Sarcoma
1
Rhabdomyosarcoma
1
Interventions
Radiotherapy
10
Vincristine
9
Dactinomycin
8
Cyclophosphamide
8
Radiation
6
Ifosfamide
6
Doxorubicin
5
Irinotecan
4
Filgrastim
4
Etoposide
4
Vinorelbine
3
sargramostim
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Granulocyte Colony-Stimulating Factor
2
Biopsy
2
trofosfamide
1
trioctyl phosphine oxide
1
temsirolimus
1
pegfilgrastim
1
etoposide phosphate
1
X-Rays
1
Topotecan
1
Surgical Procedures, Operative
1
Spinal Puncture
1
Sirolimus
1
Sentinel Lymph Node Biopsy
1
Phantoms, Imaging
1
Idarubicin
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Rhabdomyosarcoma
×
trofosfamide
×
Clear all
NCT00876031
2022-11-08
CWS-2007-HR
University Hospital Tuebingen
Phase 3
Completed
195 enrolled